Patent · US Active

Use of a sulfonamide compound for improving the pharmacokinetics of a drug

US8557854B2 · kind B2 · utility

0Cited by

0References

1Claims

0Family size

Assignee

Janssen R & D Ireland · IE

Inventors

Gerben Albert Van 'T Klooster · Breda, NL
Piet Tom Bert Paul Wigerinck · Terhagen, BE
Sandra De Meyer · Beerse, BE
Lieven Elvire Colette Baert · Brugge, BE
Herman Augustinus De Kock · Arendonk, BE

Key dates

Filing date	Apr 14, 2006
Grant date	Oct 15, 2013
Priority date	—
Expiry date	Jul 6, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for improving the pharmacokinetics of drugs, which are metabolized by cytochrome P450 monooxygenase is disclosed. More specifically it relates to a method for improving the pharmacokinetics of retroviral protease inhibitors and in particular for improving the pharmacokinetics of human immunodeficiency virus (HIV) protease inhibitors. A pharmaceutical composition and its use in the manufacture of a medicament for the inhibition or treatment of an HIV infection or AIDS in a human being are also part of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.